Non-Thermal Plasma-Induced Immunogenic Cell Death in Cancer: A Topical Review.
Journal
Journal of physics D: Applied physics
ISSN: 0022-3727
Titre abrégé: J Phys D Appl Phys
Pays: England
ID NLM: 1256300
Informations de publication
Date de publication:
22 Oct 2019
22 Oct 2019
Historique:
entrez:
6
9
2019
pubmed:
6
9
2019
medline:
6
9
2019
Statut:
ppublish
Résumé
Recent advances in biomedical research in cancer immunotherapy have identified the use of an oxidative stress-based approach to treat cancers, which works by inducing immunogenic cell death (ICD) in cancer cells. Since the anti-cancer effects of non-thermal plasma (NTP) are largely attributed to the reactive oxygen and nitrogen species that are delivered to and generated inside the target cancer cells, it is reasonable to postulate that NTP would be an effective modality for ICD induction. NTP treatment of tumors has been shown to destroy cancer cells rapidly and, under specific treatment regimens, this leads to systemic tumor-specific immunity. The translational benefit of NTP for treatment of cancer relies on its ability to enhance the interactions between NTP-exposed tumor cells and local immune cells which initiates subsequent protective immune responses. This review discusses results from recent investigations of NTP application to induce immunogenic cell death in cancer cells. With further optimization of clinical devices and treatment protocols, NTP can become an essential part of the therapeutic armament against cancer.
Identifiants
pubmed: 31485083
doi: 10.1088/1361-6463/ab31c1
pmc: PMC6726388
mid: NIHMS1047159
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : NCI NIH HHS
ID : R01 CA206026
Pays : United States
Références
J Exp Med. 1999 Dec 6;190(11):1717-22
pubmed: 10587362
Support Care Cancer. 2005 Apr;13(4):219-27
pubmed: 15538640
Nat Rev Cancer. 2006 Jul;6(7):535-45
pubmed: 16794636
Nitric Oxide. 2008 Sep;19(2):205-16
pubmed: 18503779
Nat Rev Immunol. 2009 May;9(5):353-63
pubmed: 19365408
Antioxid Redox Signal. 2009 Dec;11(12):2985-3011
pubmed: 19505186
Lancet Oncol. 2009 Jul;10(7):718-26
pubmed: 19573801
J Dtsch Dermatol Ges. 2010 Dec;8(12):968-76
pubmed: 20718902
Appl Environ Microbiol. 2010 Nov;76(22):7662-4
pubmed: 20889799
Science. 2011 Mar 25;331(6024):1565-70
pubmed: 21436444
Int J Cancer. 2012 May 1;130(9):2185-94
pubmed: 21702038
Biosens Bioelectron. 2011 Oct 15;28(1):333-8
pubmed: 21820891
Br J Cancer. 2011 Oct 25;105(9):1295-301
pubmed: 21979421
Stud Health Technol Inform. 2012;173:515-7
pubmed: 22357047
Front Oncol. 2012 Aug 24;2:102
pubmed: 22937525
BMC Cancer. 2012 Oct 15;12:473
pubmed: 23066891
PLoS One. 2012;7(12):e52653
pubmed: 23300736
J Pediatr Surg. 2013 Jan;48(1):67-73
pubmed: 23331795
Molecules. 2013 Apr 25;18(5):4917-28
pubmed: 23698040
J Clin Invest. 2013 Jul;123(7):2756-63
pubmed: 23863633
PLoS One. 2013 Aug 27;8(8):e73665
pubmed: 24013954
Biotechnol Bioeng. 2014 Mar;111(3):565-74
pubmed: 24022746
PLoS One. 2013 Sep 11;8(9):e73741
pubmed: 24040051
PLoS One. 2013 Dec 12;8(12):e82143
pubmed: 24349203
PLoS One. 2013 Dec 18;8(12):e81576
pubmed: 24367486
PLoS One. 2014 Jan 21;9(1):e86173
pubmed: 24465942
Adv Immunol. 2014;122:91-128
pubmed: 24507156
Cell Death Dis. 2014 Feb 13;5:e1056
pubmed: 24525732
Exp Dermatol. 2014 Jun;23(6):424-5
pubmed: 24750453
PLoS One. 2014 Jun 27;9(6):e101299
pubmed: 24971517
Photodiagnosis Photodyn Ther. 2005 Jun;2(2):91-106
pubmed: 25048669
Int J Mol Med. 2014 Oct;34(4):941-6
pubmed: 25050490
Biochim Biophys Acta. 2014 Dec;1843(12):2827-37
pubmed: 25173814
Semin Radiat Oncol. 2015 Jan;25(1):54-64
pubmed: 25481267
Oncoimmunology. 2014 Dec 13;3(9):e955691
pubmed: 25941621
Scand J Gastroenterol. 2015;50(11):1315-21
pubmed: 25956748
JAMA. 2015 Sep 15;314(11):1113-4
pubmed: 26348357
Cell. 2015 Sep 10;162(6):1202-5
pubmed: 26359978
Phys Plasmas. 2015 Dec;22(12):122005
pubmed: 26543345
Biointerphases. 2015 Dec 22;10(4):040801
pubmed: 26700469
Sci Rep. 2016 Jul 07;6:29048
pubmed: 27383714
Oncotarget. 2017 Feb 28;8(9):15977-15995
pubmed: 27845910
Ann Surg Oncol. 2017 May;24(5):1188-1194
pubmed: 28058557
Comb Chem High Throughput Screen. 2017;20(5):430-439
pubmed: 28302019
Int J Mol Sci. 2017 May 03;18(5):null
pubmed: 28467380
Sci Rep. 2017 Jul 20;7(1):6085
pubmed: 28729634
Trends Biotechnol. 2018 Jun;36(6):586-593
pubmed: 28755977
Oxid Med Cell Longev. 2017;2017:4396467
pubmed: 28761621
Sci Rep. 2017 Aug 16;7(1):8319
pubmed: 28814809
Trends Biotechnol. 2018 Jun;36(6):594-602
pubmed: 28843839
Sci Rep. 2017 Sep 7;7(1):10831
pubmed: 28883477
J Intern Med. 2018 Feb;283(2):110-120
pubmed: 29071761
Plasma Process Polym. 2015 Dec;12(12):1400-1409
pubmed: 29104522
J Immunol. 2018 Jan 15;200(2):450-458
pubmed: 29311387
Sci Rep. 2018 May 16;8(1):7689
pubmed: 29769707
Oncoimmunology. 2018 Jul 26;7(9):e1484978
pubmed: 30228954
Sci Rep. 2018 Oct 18;8(1):15418
pubmed: 30337623
Cancers (Basel). 2018 Oct 23;10(11):null
pubmed: 30360539
Blood Rev. 2019 Mar;34:45-55
pubmed: 30528964
Adv Sci (Weinh). 2019 Jan 28;6(6):1802062
pubmed: 30937272
J Clin Invest. 1998 Sep 15;102(6):1258-64
pubmed: 9739060